Enochian Biosciences, Inc.
ENOB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $59 | $429 | $422 | $421 |
| - Cash | $1 | $0 | $1 | $0 |
| + Debt | $3 | $10 | $7 | $6 |
| Enterprise Value | $61 | $439 | $428 | $427 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $3 | -$115 | -$4 | -$5 |
| % Margin | – | – | – | – |
| Net Income | $3 | -$127 | $0 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.13 | -0.76 | 0.001 | -0.04 |
| % Growth | 117.1% | -63,433.3% | 103% | – |
| Operating Cash Flow | -$1 | -$2 | -$1 | -$3 |
| Capital Expenditures | $0 | -$29,774 | $29,774 | $0 |
| Free Cash Flow | -$1 | -$29,776 | $11,804,307 | -$3 |